WO2026003783 - COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS (TTFIELDS) AND NF-ΚB INHIBITORS
National phase entry is expected:
Publication Number
WO/2026/003783
Publication Date
02.01.2026
International Application No.
PCT/IB2025/056523
International Filing Date
26.06.2025
Title **
[English]
COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS (TTFIELDS) AND NF-ΚB INHIBITORS
[French]
COMPOSITIONS, SYSTÈMES ET MÉTHODES DE TRAITEMENT DU CANCER À L'AIDE DE CHAMPS DE TRAITEMENT DE TUMEURS (TTFIELDS) ET D'INHIBITEURS DE NF-ΚB
Applicants **
NOVOCURE GMBH
Inventors
LAVY-SHAHAF, Gitit
VOLOSHIN-SELA, Tali
AVIGDOR, Lilach
Priority Data
63/664,925
27.06.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2177 | |
| EPO | Filing, Examination, Granting | 8725 | |
| Japan | Filing, Examination, Granting | 2155 | |
| South Korea | Filing, Examination, Granting | 2071 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
19,868
Contact Us
Abstract[English]
Compositions, kits, systems, and methods for reducing viability of cancer cells and treating cancer, as well as reducing a volume of a tumor and/or preventing an increase in volume of a tumor present in a body of a living subject, are disclosed. The systems and methods involve application of an alternating field in combination with administration of at least one composition comprising at least one NF-κB inhibitor.[French]
L'invention concerne des compositions, des kits, des systèmes et des procédés de réduction de la viabilité de cellules cancéreuses et de traitement du cancer, ainsi que de réduction d'un volume d'une tumeur et/ou de prévention d'une augmentation du volume d'une tumeur présente dans un corps d'un sujet vivant. Les systèmes et les procédés impliquent l'application d'un champ alternatif en combinaison avec l'administration d'au moins une composition comprenant au moins un inhibiteur de NF-κB.